α-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial

The Lancet · 2004 · 896 citations

Medicine, Pharmacology, Pharmacotherapy +14

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

Bengt Winblad, Knut Engedal, Hilkka Soininen et al. · Neurology · 2001 · 731 citations

Medicine, Pharmacology, Pharmacotherapy +16

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration

Robert G. Stern, Richard C. Mohs, Michael H. Davidson et al. · American Journal of Psychiatry · 1994 · 410 citations

Medicine, Neurology, Psychology +17

Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study

Willem A. van Gool, Henry C. Weinstein, Philip Scheltens et al. · The Lancet · 2001 · 214 citations

Medicine, Neurology, Pharmacology +13

Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease

George Perry, Rudy J. Castellani, Keisuke Hirai et al. · Journal of Alzheimer s Disease · 1998 · 187 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17